Tumour regression after systemic administration of a novel targeted vitamin E therapeutic system

J.Y. Fu, L. Tetley, D. Blatchford, C. Dufès

Research output: Contribution to journalArticle

Abstract

Tocotrienol, an extract of vitamin E, has been shown to exert antiproliferative and tumour suppressive effects on cancer cells.However, its therapeutic potential is currently limited by its failure to reach tumours after intravenous administration, without secondary effects on normal tissues. The objectives of this study are to prepare and characterise novel transferrin-targeted vesicles encapsulating tocotrienol, able to recognise transferrin receptors overexpressed on many cancer cell lines and to evaluate in vitro and in vivo the therapeutic and targeting efficacies of this therapeutic system.
LanguageEnglish
PagesA42-A42
JournalJournal of Pharmacy and Pharmacology
Volume61
Issue numberS1
DOIs
Publication statusPublished - 2009

Fingerprint

Vitamin E
Tocotrienols
Neoplasms
Transferrin Receptors
Transferrin
Intravenous Administration
Therapeutics
Cell Line

Keywords

  • tumour regression
  • vitamin E
  • therapeutic system
  • tocotrienol

Cite this

Fu, J.Y. ; Tetley, L. ; Blatchford, D. ; Dufès, C. / Tumour regression after systemic administration of a novel targeted vitamin E therapeutic system. In: Journal of Pharmacy and Pharmacology. 2009 ; Vol. 61, No. S1. pp. A42-A42.
@article{ba2ffad6dce146218844fd57cc946ed0,
title = "Tumour regression after systemic administration of a novel targeted vitamin E therapeutic system",
abstract = "Tocotrienol, an extract of vitamin E, has been shown to exert antiproliferative and tumour suppressive effects on cancer cells.However, its therapeutic potential is currently limited by its failure to reach tumours after intravenous administration, without secondary effects on normal tissues. The objectives of this study are to prepare and characterise novel transferrin-targeted vesicles encapsulating tocotrienol, able to recognise transferrin receptors overexpressed on many cancer cell lines and to evaluate in vitro and in vivo the therapeutic and targeting efficacies of this therapeutic system.",
keywords = "tumour regression, vitamin E, therapeutic system, tocotrienol",
author = "J.Y. Fu and L. Tetley and D. Blatchford and C. Duf{\`e}s",
year = "2009",
doi = "10.1211/002235709789036991",
language = "English",
volume = "61",
pages = "A42--A42",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
number = "S1",

}

Tumour regression after systemic administration of a novel targeted vitamin E therapeutic system. / Fu, J.Y.; Tetley, L.; Blatchford, D.; Dufès, C.

In: Journal of Pharmacy and Pharmacology, Vol. 61, No. S1, 2009, p. A42-A42.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tumour regression after systemic administration of a novel targeted vitamin E therapeutic system

AU - Fu, J.Y.

AU - Tetley, L.

AU - Blatchford, D.

AU - Dufès, C.

PY - 2009

Y1 - 2009

N2 - Tocotrienol, an extract of vitamin E, has been shown to exert antiproliferative and tumour suppressive effects on cancer cells.However, its therapeutic potential is currently limited by its failure to reach tumours after intravenous administration, without secondary effects on normal tissues. The objectives of this study are to prepare and characterise novel transferrin-targeted vesicles encapsulating tocotrienol, able to recognise transferrin receptors overexpressed on many cancer cell lines and to evaluate in vitro and in vivo the therapeutic and targeting efficacies of this therapeutic system.

AB - Tocotrienol, an extract of vitamin E, has been shown to exert antiproliferative and tumour suppressive effects on cancer cells.However, its therapeutic potential is currently limited by its failure to reach tumours after intravenous administration, without secondary effects on normal tissues. The objectives of this study are to prepare and characterise novel transferrin-targeted vesicles encapsulating tocotrienol, able to recognise transferrin receptors overexpressed on many cancer cell lines and to evaluate in vitro and in vivo the therapeutic and targeting efficacies of this therapeutic system.

KW - tumour regression

KW - vitamin E

KW - therapeutic system

KW - tocotrienol

UR - http://dx.doi.org/10.1211/002235709789036991

U2 - 10.1211/002235709789036991

DO - 10.1211/002235709789036991

M3 - Article

VL - 61

SP - A42-A42

JO - Journal of Pharmacy and Pharmacology

T2 - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - S1

ER -